Christopher Murphy
Finanzdirektor/CFO bei THIRD HARMONIC BIO, INC.
Profil
Christopher M.
Murphy is currently the Chief Financial & Business Officer at Third Harmonic Bio, Inc. Prior to this, he worked as the Group Vice President-Commercial Operations at Horizon Therapeutics Plc.
He completed his undergraduate degree at the University of Notre Dame.
Aktive Positionen von Christopher Murphy
| Unternehmen | Position | Beginn |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Finanzdirektor/CFO | 04.01.2024 |
Ehemalige bekannte Positionen von Christopher Murphy
| Unternehmen | Position | Ende |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Ausbildung von Christopher Murphy
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THIRD HARMONIC BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
